Sullivan, Bruyette, Speros & Blaney’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.39M	Hold	124,303	–	–	0.06%	94
2020 Q4	$1.42M	Hold	124,303	–	–	0.07%	89
2020 Q3	$1.12M	Hold	124,303	–	–	0.06%	92
2020 Q2	$1.28M	Hold	124,303	–	–	0.08%	83
2020 Q1	$1.25M	Sell	124,303 -13,000	-9%	-$153K	0.09%	70
2019 Q4	$1.83M	Hold	137,303	–	–	0.1%	57
2019 Q3	$1.18M	Sell	137,303 -10,000	-7%	-$97.2K	0.07%	75
2019 Q2	$1.61M	Sell	147,303 -28,577	-16%	-$320K	0.1%	59
2019 Q1	$1.99M	Buy	175,880 +129,135	+276%	+$1.44M	0.12%	45
2018 Q4	$406K	Hold	46,745	–	–	0.03%	125
2018 Q3	$723K	Hold	46,745	–	–	0.07%	73
2018 Q2	$749K	Hold	46,745	–	–	0.07%	68
2018 Q1	$604K	Buy	46,745 +2,507	+6%	+$31.2K	0.06%	75
2017 Q4	$555K	Hold	44,238	–	–	0.05%	85
2017 Q3	$584K	Hold	44,238	–	–	0.06%	81
2017 Q2	$700K	Hold	44,238	–	–	0.07%	69
2017 Q1	$632K	Buy	44,238 +4,239	+11%	+$58K	0.06%	71
2016 Q4	$512K	Buy	+39,999	New	+$505K	0.05%	82

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's IRWD Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2021 at 124,303 shares worth $1.39M. The position accounts for 0.06% of the portfolio, ranked #94.

Sullivan, Bruyette, Speros & Blaney first reported a position in IRWD in Q4 2016 and has held it in 18 quarters since. The position peaked at $1.99M in Q1 2019. 210 funds tracked by Wall St. Rank hold IRWD as of Q1 2021.

Sullivan, Bruyette, Speros & Blaney held 124,303 shares of Ironwood Pharmaceuticals worth $1.39M as of Q1 2021.
Sullivan, Bruyette, Speros & Blaney left its Ironwood Pharmaceuticals share count unchanged in Q1 2021.
Ironwood Pharmaceuticals made up 0.06% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #94 holding.
Sullivan, Bruyette, Speros & Blaney first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 18 quarters since.
Sullivan, Bruyette, Speros & Blaney's Ironwood Pharmaceuticals position peaked at $1.99M in Q1 2019.
210 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.